Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Calidi Biotherapeutics, Inc. | CEO and Chairman of the Board, Director, 10%+ Owner | Common Stock | 76.7K | $88.2K | $1.15 | Sep 26, 2024 | Direct |
Calidi Biotherapeutics, Inc. | CEO and Chairman of the Board, Director, 10%+ Owner | Non-Qualified Stock Options (right to buy) | 100K | Dec 21, 2023 | Direct | ||
Calidi Biotherapeutics, Inc. | CEO and Chairman of the Board, Director, 10%+ Owner | Stock Options (right to buy) | 40K | Jun 17, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CLDI | Calidi Biotherapeutics, Inc. | Sep 26, 2024 | 1 | $80.7K | 4 | Sep 30, 2024 | CEO and Chairman of the Board, Director, 10%+ Owner |
CLDI | Calidi Biotherapeutics, Inc. | Jun 17, 2024 | 1 | $0 | 4 | Jun 20, 2024 | CEO and Chairman of the Board, Director, 10%+ Owner |
CLDI | Calidi Biotherapeutics, Inc. | Dec 21, 2023 | 1 | $0 | 4 | Jan 4, 2024 | CEO, President and Chairman, Director, 10%+ Owner |
FLAG | Calidi Biotherapeutics, Inc. | Sep 12, 2023 | 0 | $0 | 3 | Sep 25, 2023 | CEO, President and Chairman, Director, 10%+ Owner |